PDCD1 and glioblastoma: A recent study in a mouse orthotopic GBM model showed that combining steteotactic radiation with anti-PD-1 blockade increased the tumor-infiltrating cytotoxic T cells while reduced tumor-associated Tregs, resulting in prolonged mouse survival [142].